Muscle Growth Peptides
Peptides studied in the context of muscle hypertrophy and growth hormone.
TB-500
Medium EvidenceA naturally occurring peptide involved in cell migration and tissue repair, studied for wound healing and recovery.
CJC-1295
Medium EvidenceA growth hormone releasing hormone analog studied for stimulating growth hormone secretion.
Ipamorelin
Medium EvidenceA selective growth hormone secretagogue studied for targeted GH release with fewer side effects than other GH peptides.
MOTS-c
Low EvidenceA mitochondrial-derived peptide studied for metabolic regulation, exercise mimetic effects, and longevity.
Tesamorelin
High EvidenceA GHRH analog FDA-approved for reducing visceral fat in HIV-associated lipodystrophy.
Sermorelin
Medium EvidenceA GHRH analog previously FDA-approved for growth hormone deficiency diagnosis and treatment.
CJC-1295 (DAC)
Medium EvidenceA long-acting GHRH analog with an extended half-life due to its Drug Affinity Complex modification.
GHRP-6
Medium EvidenceA growth hormone secretagogue that also stimulates appetite through ghrelin receptor activation.
GHRP-2
Medium EvidenceA synthetic hexapeptide growth hormone secretagogue studied for its potent stimulation of growth hormone release via the ghrelin receptor.
IGF-1 LR3
Medium EvidenceA modified form of IGF-1 with extended half-life, studied for muscle growth and tissue development.
IGF-DES
Low EvidenceA truncated form of IGF-1 with high potency and rapid local activity at the site of administration.
PEG-MGF
Low EvidenceA PEGylated splice variant of IGF-1 studied for muscle repair and satellite cell activation, with an extended half-life compared to native MGF.
Track Your Research with PepTracker Pro
Open PepTracker Pro